Health Economics
Health economic models and analyses help decision-makers evaluate the expected health and cost outcomes of the introduction of a new healthcare intervention.
Models and analyses can be used for scientific use in articles in peer review journals or presentations at international conferences, and early models can guide the development of new therapies and policies.
Our services include
- Development of de novo models – from conceptualization to validation
- Adaptation of company models to local Danish or Nordic setting. We work with all types of models (e.g. Markov, Decision Trees, Part. Survival).
Early modelling
- Value demonstration
- Funding applications
- Pricing strategies
Our team of experts are specialized in developing economic models that help stakeholders make informed decisions about the value and impact of health innovations, from new pharmaceuticals, medical devices, guideline development to broader public health initiatives. Models can be constructed in different formats and with different structures (e.g Markov, decision trees, partitioned survival etc.). We conduct health economic evaluations alongside clinical trials, as well as early modeling based on expert opinions and existing literature.
Contact Nordic Institute of Health Economics A/S
We are always happy to have an informal chat about your future research project. Please do not hesitate to contact us and we will set up a meeting.
Phone:
+45 25 35 45 41
Email:
info@nih-economics.dk